NL-OMON48348招募中不适用
Prostate cancer Immune profiling before, during and after HDR-brachytherapy in local relapsed prostate cancer. - PRIMUS
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Local relapse of prostate cancer, who is candidate for a salvage HDR
- •- 18 years or older
- •- Willing and able to comply with the study prescriptions.
- •- Before patient registration, written informed consent must be given according
- •to ICH/GCP, and national/local regulations.
排除标准
- •- Not eligible for proposed (HDR brachytherapy) treatment.
- •- No compliance
研究者
相似试验
已完成
不适用
Immune Profiling After HDR in Local Relapsed Prostate CancerPD-L1Prostate CancerNCT04247217Maastricht Radiation Oncology10
尚未招募
不适用
Analysis of prostrate-specific immunity in stage III and IV prostate cancer patients10038597prostate cancerNL-OMON32487KI-AV50
尚未招募
2 期
A continence promotion intervention involving a pelvic floor muscle rehabilitation exercise program to reduce lower urinary tract, lower bowel symptoms and erectile dysfunction in men receiving radiation therapy with or without androgen deprivation therapy (ADT): A Pilot StudyProstate Cancer TreatmentLower Urinary Tract sequelae to radiation therapy with or without androgen deprivation therapyLower Bowel Dysfunction as sequelae to radiation therapy with or without androgen deprivation therapyErectile Dysfunction as sequelae to radiation therapy with or without androgen deprivation therapyCancer - ProstatePhysical Medicine / Rehabilitation - PhysiotherapyRenal and Urogenital - Other renal and urogenital disordersACTRN12612000527864niversity of Newcastle40
撤回
2 期
N-803 Alone or in Combination With BN-Brachyury Vaccine or Bintrafusp Alfa (M7824) for Participants With Castration Resistant Prostate CancerCastration Resistant Prostate CancerNCT05445882National Cancer Institute (NCI)
已完成
不适用
Detecting prostate cancer by the intracellular presence of prostate-specific antigen in macrophages, detected in peripheral blood samples by a flow cytometric technique.benign prostate hypertrophiaprostate carcinoma10038364NL-OMON37430Atrium Medisch Centrum150